Article Details
Retrieved on: 2021-11-09 21:53:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Biohaven and Pfizer have partnered to market the Connecticut-based company's migraine drug Nurtec ODT (rimegepant) outside the U. S. once approved ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here